{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:11:01Z","timestamp":1783955461604,"version":"3.55.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Doctoral research start-up foundation of the Second Affiliated Hospital of Anhui Medical University","award":["JF20250035"],"award-info":[{"award-number":["JF20250035"]}]},{"name":"The Open project Fund of the Key Laboratory of Pharmaceutical Research and Clinical Evaluation of innovative Drugs in Anhui Province","award":["KFKT202402"],"award-info":[{"award-number":["KFKT202402"]}]},{"name":"Anhui Provincial Department of Education Scientific Research Project","award":["2025AHGXZK40463"],"award-info":[{"award-number":["2025AHGXZK40463"]}]},{"name":"Anhui Provincial Department of Education Scientific Research Project","award":["2023AH053166"],"award-info":[{"award-number":["2023AH053166"]}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["2508085MH195"],"award-info":[{"award-number":["2508085MH195"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["2508085J050, 2508085MH195"],"award-info":[{"award-number":["2508085J050, 2508085MH195"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82373932"],"award-info":[{"award-number":["82373932"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Department of Education of Anhui Province Outstanding Young Teacher Training Project","award":["YQZD2023023"],"award-info":[{"award-number":["YQZD2023023"]}]},{"name":"Anhui Medical University 2025 Undergraduate Innovation Training Programme Approved Projects","award":["X202410366137, S202510366114, X202510366156"],"award-info":[{"award-number":["X202410366137, S202510366114, X202510366156"]}]},{"name":"Anhui Provincial Research Project on the Inheritance and Innovation of Traditional Chinese Medicine","award":["2025CCCX164"],"award-info":[{"award-number":["2025CCCX164"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Liver fibrosis is a representative scarring response that can ultimately lead to liver cancer. However, relevant antifibrotic drugs for the effective treatment of liver fibrosis in humans have not yet been identified. 6-Shogaol is derived from natural products and exhibits multiple biological activities, including anti-inflammatory and antioxidant properties; however, its efficacy and potential mechanism of action against liver fibrosis remains unclear. This study aimed to examine the anti-fibrotic properties and potential mechanisms of action of 6-Shogaol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Two liver fibrosis mouse\u00a0models (carbon tetrachloride (CCl\n                      <jats:sub>4<\/jats:sub>\n                      ) and bile duct ligation (BDL)) were constructed to evaluate the anti-fibrotic properties of 6-Shogaol\n                      <jats:italic>in vivo<\/jats:italic>\n                      . Transforming growth factor-\u03b21 (TGF-\u03b21)-induced human hepatic stellate cells (HSCs) LX-2 cells were used as\n                      <jats:italic>in vitro<\/jats:italic>\n                      models. Network pharmacology analysis was introduced to explore the key targets of 6-Shogaol regarding the mechanisms on liver fibrosis. Molecular docking, molecular dynamics simulations, drug affinity reactivity target stability (DARTS) and isothermal titration calorimetry (ITC) were used to detect the affinity and binding between 6-Shogaol and its target. Additionally, we invested the mechanism of 6-Shogaol through RNA sequencing combined with Western blotting, oxygen consumption rate (OCR), extracellular acidification rate (ECAR), immunofluorescence co-localization, histopathology, immunohistochemical staining and RT-qPCR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The results showed that 6-Shogaol remarkably alleviated CCl\n                      <jats:sub>4<\/jats:sub>\n                      - and BDL-induced liver fibrosis in mice, including observations of improved liver function, decreased activity of HSCs, and decreased extracellular matrix (ECM) deposition. In an\n                      <jats:italic>in vitro<\/jats:italic>\n                      model, 6-Shogaol suppressed TGF-\u03b21-induced LX-2 activation. Mechanistically, RNA sequence analysis revealed that the effect of 6-Shogaol on liver fibrosis is linked to glycolytic reprogramming. 6-Shogaol suppressed HSCs glycolysis by decreasing glycolytic enzymes (HK2, PKM2, and GLUT1) and glycolytic metabolite levels (lactic acid and pyruvic acid). Furthermore, network pharmacology suggested HIF-1\u03b1 as a potential 6-Shogaol target. Molecular docking, molecular dynamics simulations, DARTS, and ITC confirmed that 6-Shogaol could directly bind to HIF-1\u03b1. Interestingly, we demonstrated that HIF-1\u03b1 knockout significantly inhibited HSCs glycolysis and activation, whereas the overexpression of HIF-1\u03b1 increased HSCs glycolysis and activation. Moreover, specific knockout of HIF-1\u03b1 did not enhance the suppressive effect of 6-Shogaol on HSCs activation or fibrosis-associated protein expression\n                      <jats:italic>in vivo<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings showed that 6-Shogaol ameliorated liver fibrosis by modulating the expression of HIF-1\u03b1 associated with glycolysis reprogramming and validate 6-Shogaol as a promising therapeutic strategy for liver fibrosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-026-01396-y","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T06:51:51Z","timestamp":1779864711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["6-Shogaol inhibits HSCs activation and liver fibrosis by regulating glycolytic reprogramming via targeting HIF-1\u03b1"],"prefix":"10.1186","volume":"21","author":[{"given":"Junfa","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuansong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"Suppl 1","key":"1396_CR1","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","volume":"38","author":"SL Friedman","year":"2003","unstructured":"Friedman SL. Liver fibrosis \u2013 from bench to bedside. J Hepatol. 2003;38(Suppl 1):S38-53.","journal-title":"J Hepatol"},{"key":"1396_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","volume":"68-69","author":"D Schuppan","year":"2018","unstructured":"Schuppan D, Ashfaq-Khan M, Yang AT, Kim YO. Liver fibrosis: direct antifibrotic agents and targeted therapies. Matrix Biol. 2018;68\u201369:435\u201351.","journal-title":"Matrix Biol"},{"issue":"7","key":"1396_CR3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908\u201322.","journal-title":"Nat Med"},{"issue":"1","key":"1396_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/egastro-2023-100040","volume":"2","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wang L. Extracellular vesicles targeting non-parenchymal cells: the therapeutical effect on liver fibrosis. eGastroenterology. 2024;2(1):e100040.","journal-title":"eGastroenterology"},{"issue":"38","key":"1396_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo0987","volume":"8","author":"S Gao","year":"2022","unstructured":"Gao S, Li X, Jiang Q, Liang Q, Zhang F, Li S, et al. PKM2 promotes pulmonary fibrosis by stabilizing TGF-\u03b21 receptor I and enhancing TGF-\u03b21 signaling. Sci Adv. 2022;8(38):eabo0987.","journal-title":"Sci Adv"},{"issue":"12","key":"1396_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06347-1","volume":"14","author":"S Yang","year":"2023","unstructured":"Yang S, Wu H, Li Y, Li L, Xiang J, Kang L, et al. Inhibition of PFKP in renal tubular epithelial cell restrains TGF-\u03b2 induced glycolysis and renal fibrosis. Cell Death Dis. 2023;14(12):816.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1396_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41573-019-0040-5","volume":"19","author":"X Zhao","year":"2020","unstructured":"Zhao X, Kwan JYY, Yip K, Liu PP, Liu FF. Targeting metabolic dysregulation for fibrosis therapy. Nat Rev Drug Discov. 2020;19(1):57\u201375.","journal-title":"Nat Rev Drug Discov"},{"issue":"5930","key":"1396_CR8","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (New York, NY). 2009;324(5930):1029\u201333.","journal-title":"Science (New York, NY)"},{"issue":"4","key":"1396_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107954","volume":"32","author":"A Kogot-Levin","year":"2020","unstructured":"Kogot-Levin A, Hinden L, Riahi Y, Israeli T, Tirosh B, Cerasi E, et al. Proximal tubule mTORC1 is a central player in the pathophysiology of diabetic nephropathy and its correction by SGLT2 inhibitors. Cell Rep. 2020;32(4):107954.","journal-title":"Cell Rep"},{"issue":"12","key":"1396_CR10","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1164\/rccm.201504-0780OC","volume":"192","author":"N Xie","year":"2015","unstructured":"Xie N, Tan Z, Banerjee S, Cui H, Ge J, Liu RM, et al. Glycolytic reprogramming in myofibroblast differentiation and lung fibrosis. Am J Respir Crit Care Med. 2015;192(12):1462\u201374.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1396_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1053\/j.gastro.2020.03.008","volume":"159","author":"M Mejias","year":"2020","unstructured":"Mejias M, Gallego J, Naranjo-Suarez S, Ramirez M, Pell N, Manzano A, et al. CPEB4 increases expression of PFKFB3 to induce glycolysis and activate mouse and human hepatic stellate cells, promoting liver fibrosis. Gastroenterology. 2020;159(1):273\u201388.","journal-title":"Gastroenterology"},{"issue":"22","key":"1396_CR12","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1111\/bph.15908","volume":"179","author":"P Gratal","year":"2022","unstructured":"Gratal P, Mediero A, Lamuedra A, Matamoros-Recio A, Herencia C, Herrero-Beaumont G, et al. 6-Shogaol (enexasogoal) treatment improves experimental knee osteoarthritis exerting a pleiotropic effect over immune innate signalling responses in chondrocytes. Br J Pharmacol. 2022;179(22):5089\u2013108.","journal-title":"Br J Pharmacol"},{"key":"1396_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.biopha.2017.10.084","volume":"97","author":"Y Xu","year":"2018","unstructured":"Xu Y, Bai L, Chen X, Li Y, Qin Y, Meng X, et al. 6-Shogaol ameliorates diabetic nephropathy through anti-inflammatory, hyperlipidemic, anti-oxidative activity in db\/db mice. Biomed Pharmacother. 2018;97:633\u201341.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"1396_CR14","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1021\/jf504934m","volume":"63","author":"YL Hsu","year":"2015","unstructured":"Hsu YL, Hung JY, Tsai YM, Tsai EM, Huang MS, Hou MF, et al. 6-shogaol, an active constituent of dietary ginger, impairs cancer development and lung metastasis by inhibiting the secretion of CC-chemokine ligand 2 (CCL2) in tumor-associated dendritic cells. J Agric Food Chem. 2015;63(6):1730\u20138.","journal-title":"J Agric Food Chem"},{"key":"1396_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110302","volume":"128","author":"AS Bawadood","year":"2020","unstructured":"Bawadood AS, Al-Abbasi FA, Anwar F, El-Halawany AM, Al-Abd AM. 6-Shogaol suppresses the growth of breast cancer cells by inducing apoptosis and suppressing autophagy via targeting Notch signaling pathway. Biomed Pharmacother. 2020;128:110302.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1396_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.canlet.2013.04.014","volume":"336","author":"BS Tan","year":"2013","unstructured":"Tan BS, Kang O, Mai CW, Tiong KH, Khoo AS, Pichika MR, et al. 6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor \u03b3 (PPAR\u03b3). Cancer Lett. 2013;336(1):127\u201339.","journal-title":"Cancer Lett"},{"key":"1396_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2024.140197","volume":"457","author":"W Jiao","year":"2024","unstructured":"Jiao W, Jiao Y, Sang Y, Wang X, Wang S. 6-Shogaol alleviates high-fat diet induced hepatic steatosis through miR-3066-5p\/Grem2 pathway. Food Chem. 2024;457:140197.","journal-title":"Food Chem"},{"key":"1396_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29020419","author":"AY Yang","year":"2024","unstructured":"Yang AY, Kim K, Kwon HH, Leem J, Song JE. 6-Shogaol ameliorates liver inflammation and fibrosis in mice on a methionine- and choline-deficient diet by inhibiting oxidative stress, cell death, and endoplasmic reticulum stress. Molecules. 2024. https:\/\/doi.org\/10.3390\/molecules29020419.","journal-title":"Molecules"},{"issue":"5","key":"1396_CR19","doi-asserted-by":"publisher","first-page":"11907","DOI":"10.1080\/21655979.2022.2065945","volume":"13","author":"H Tu","year":"2022","unstructured":"Tu H, Wang W, Feng Y, Zhang L, Zhou H, Cheng C, et al. beta-Patchoulene represses hypoxia-induced proliferation and epithelial-mesenchymal transition of liver cancer cells. Bioengineered. 2022;13(5):11907\u201322.","journal-title":"Bioengineered"},{"issue":"2","key":"1396_CR20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","volume":"40","author":"AJ Majmundar","year":"2010","unstructured":"Majmundar AJ, Wong WJ, Simon MC. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell. 2010;40(2):294\u2013309.","journal-title":"Mol Cell"},{"issue":"5","key":"1396_CR21","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/all.16361","volume":"80","author":"X Zhang","year":"2025","unstructured":"Zhang X, Liu J, Li X, Zheng G, Wang T, Sun H, et al. Blocking the HIF-1alpha\/glycolysis axis inhibits allergic airway inflammation by reducing ILC2 metabolism and function. Allergy. 2025;80(5):1309\u201334.","journal-title":"Allergy"},{"key":"1396_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111075","volume":"117","author":"Z Tong","year":"2024","unstructured":"Tong Z, Du X, Zhou Y, Jing F, Ma J, Feng Y, et al. Drp1-mediated mitochondrial fission promotes pulmonary fibrosis progression through the regulation of lipid metabolic reprogramming by ROS\/HIF-1alpha. Cell Signal. 2024;117:111075.","journal-title":"Cell Signal"},{"issue":"1","key":"1396_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57530-1","volume":"16","author":"H Qi","year":"2025","unstructured":"Qi H, Gao H, Li M, Sun T, Gu X, Wei L, et al. Parvimonas micra promotes oral squamous cell carcinoma metastasis through TmpC-CKAP4 axis. Nat Commun. 2025;16(1):2305.","journal-title":"Nat Commun"},{"issue":"1","key":"1396_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13158","volume":"55","author":"S Yuan","year":"2022","unstructured":"Yuan S, Wei C, Liu G, Zhang L, Li J, Li L, et al. Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1alpha\/SLC7A11 pathway. Cell Prolif. 2022;55(1):e13158.","journal-title":"Cell Prolif"},{"key":"1396_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.150130","volume":"721","author":"T Sun","year":"2024","unstructured":"Sun T, Li S, Li X, Lei Y, Wang B, Liu X, et al. Apigenin intervenes in liver fibrosis by regulating PKM2-HIF-1alpha mediated oxidative stress. Biochem Biophys Res Commun. 2024;721:150130.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1396_CR26","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1142\/S0192415X2350057X","volume":"51","author":"Y Liu","year":"2023","unstructured":"Liu Y, He CY, Yang XM, Chen WC, Zhang MJ, Zhong XD, et al. Paeoniflorin coordinates macrophage polarization and mitigates liver inflammation and fibrogenesis by targeting the NF-[Formula: see text]B\/HIF-1alpha pathway in CCl(4)-induced liver fibrosis. Am J Chin Med. 2023;51(5):1249\u201367.","journal-title":"Am J Chin Med"},{"issue":"1","key":"1396_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08618-y","volume":"10","author":"B Ma","year":"2019","unstructured":"Ma B, Cheng H, Mu C, Geng G, Zhao T, Luo Q, et al. The SIAH2-NRF1 axis spatially regulates tumor microenvironment remodeling for tumor progression. Nat Commun. 2019;10(1):1034.","journal-title":"Nat Commun"},{"issue":"5","key":"1396_CR28","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.gendis.2022.04.003","volume":"10","author":"Q Yan","year":"2023","unstructured":"Yan Q, Sun Y-s, An R, Liu F, Fang Q, Wang Z, et al. Application and progress of the detection technologies in hepatocellular carcinoma. Genes Dis. 2023;10(5):1857\u201369.","journal-title":"Genes Dis"},{"issue":"10","key":"1396_CR29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2404899122","volume":"122","author":"J Gao","year":"2025","unstructured":"Gao J, Liu R, Huang K, Li Z, Sheng X, Chakraborty K, et al. Dynamic investigation of hypoxia-induced L-lactylation. Proc Natl Acad Sci U S A. 2025;122(10):e2404899122.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"29","key":"1396_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202417128","volume":"12","author":"LN Zhao","year":"2025","unstructured":"Zhao LN, Wang RL, Liu RX, Zheng MR, Zhao L, Li BF, et al. Pyruvate Carboxylase in macrophages aggravates atherosclerosis by regulating metabolism reprogramming to promote inflammatory responses through the Hypoxia-Inducible Factor-1 signaling pathway. Adv Sci. 2025;12(29):e17128.","journal-title":"Adv Sci"},{"issue":"3","key":"1396_CR31","first-page":"205","volume":"2","author":"BW Matore","year":"2025","unstructured":"Matore BW, Murmu A, Singh J, Roy PP. Combinatorial design of Imidazole\/Triazole linked Aryl-Substituted derivatives as CYP17 inhibitors exploring Hansch and molecular docking approach. Medinformatics. 2025;2(3):205\u201318.","journal-title":"Medinformatics"},{"issue":"5","key":"1396_CR32","doi-asserted-by":"publisher","first-page":"7587","DOI":"10.1002\/jcp.27521","volume":"234","author":"J Yang","year":"2019","unstructured":"Yang J, Lu Y, Yang P, Chen Q, Wang Y, Ding Q, et al. MicroRNA-145 induces the senescence of activated hepatic stellate cells through the activation of p53 pathway by ZEB2. J Cell Physiol. 2019;234(5):7587\u201399.","journal-title":"J Cell Physiol"},{"key":"1396_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.172927","volume":"871","author":"J Yang","year":"2020","unstructured":"Yang J, Tao Q, Zhou Y, Chen Q, Li L, Hu S, et al. MicroRNA-708 represses hepatic stellate cells activation and proliferation by targeting ZEB1 through Wnt\/beta-catenin pathway. Eur J Pharmacol. 2020;871:172927.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1396_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03277-0","volume":"12","author":"C Mo","year":"2021","unstructured":"Mo C, Xie S, Liu B, Zhong W, Zeng T, Huang S, et al. Indoleamine 2,3-dioxygenase 1 limits hepatic inflammatory cells recruitment and promotes bile duct ligation-induced liver fibrosis. Cell Death Dis. 2021;12(1):16.","journal-title":"Cell Death Dis"},{"key":"1396_CR35","first-page":"1","volume":"18","author":"KA Attallah","year":"2025","unstructured":"Attallah KA, El-Dessouki AM, Abd-Elmawla MA, Ghaiad HR, Abo-Elghiet F, Mustafa AM, et al. The therapeutic potential of naturally occurring 6-shogaol: an updated comprehensive review. Inflammopharmacology. 2025;18:1.","journal-title":"Inflammopharmacology"},{"issue":"2","key":"1396_CR36","first-page":"363","volume":"69","author":"JL Qiu","year":"2022","unstructured":"Qiu JL, Chai YN, Duan FY, Zhang HJ, Han XY, Chen LY, et al. 6-Shogaol alleviates CCl4-induced liver fibrosis by attenuating inflammatory response in mice through the NF-kappaB pathway. Acta Biochim Pol. 2022;69(2):363\u201370.","journal-title":"Acta Biochim Pol"},{"issue":"8","key":"1396_CR37","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1080\/03639045.2019.1594885","volume":"45","author":"Q Yang","year":"2019","unstructured":"Yang Q, Wang Q, Feng Y, Wei Q, Sun C, Firempong CK, et al. Anti-hyperuricemic property of 6-shogaol via self-micro emulsifying drug delivery system in model rats: formulation design, in vitro and in vivo evaluation. Drug Dev Ind Pharm. 2019;45(8):1265\u201376.","journal-title":"Drug Dev Ind Pharm"},{"key":"1396_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11030107","author":"H Zhang","year":"2019","unstructured":"Zhang H, Wang Q, Sun C, Zhu Y, Yang Q, Wei Q, et al. Enhanced oral bioavailability, anti-tumor activity and hepatoprotective effect of 6-shogaol loaded in a type of novel micelles of polyethylene glycol and linoleic acid conjugate. Pharmaceutics. 2019. https:\/\/doi.org\/10.3390\/pharmaceutics11030107.","journal-title":"Pharmaceutics"},{"key":"1396_CR39","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3389\/fphar.2017.00980","volume":"8","author":"J Yang","year":"2017","unstructured":"Yang J, Liu Q, Cao S, Xu T, Li X, Zhou D, et al. MicroRNA-145 increases the apoptosis of activated hepatic stellate cells induced by TRAIL through NF-kappaB signaling pathway. Front Pharmacol. 2017;8:980.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1396_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.47852\/bonviewMEDIN32021554","volume":"1","author":"S Charles","year":"2024","unstructured":"Charles S, Natarajan J. Identification of key gene modules and novel transcription factors in Tetralogy of Fallot using machine learning and network topological features. Medinformatics. 2024;1(1):27\u201334.","journal-title":"Medinformatics"},{"key":"1396_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-016-0280-y","volume":"16","author":"H Wang","year":"2016","unstructured":"Wang H, Wang L, Zhang Y, Wang J, Deng Y, Lin D. Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth. Cancer Cell Int. 2016;16:9.","journal-title":"Cancer Cell Int"},{"issue":"12","key":"1396_CR42","doi-asserted-by":"publisher","first-page":"5926","DOI":"10.7150\/thno.56490","volume":"11","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Lin F, Wan T, Chen A, Wang H, Jiang B, et al. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM. Theranostics. 2021;11(12):5926\u201338.","journal-title":"Theranostics"},{"issue":"1","key":"1396_CR43","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0168-8278(05)80181-3","volume":"19","author":"JL Poo","year":"1993","unstructured":"Poo JL, Feldmann G, Moreau A, Gaudin C, Lebrec D. Early colchicine administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation. J Hepatol. 1993;19(1):90\u20134.","journal-title":"J Hepatol"},{"issue":"2","key":"1396_CR44","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hep.32285","volume":"75","author":"SL Friedman","year":"2022","unstructured":"Friedman SL, Pinzani M. Hepatic fibrosis 2022: unmet needs and a blueprint for the future. Hepatology (Baltimore, MD). 2022;75(2):473\u201388.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"2","key":"1396_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/med4.23","volume":"1","author":"Y-F Xu","year":"2023","unstructured":"Xu Y-F, Zhao Z-B, Yan EP, Lian Z-X, Zhang W. Complex interplay between the immune system, metabolism, and epigenetic factors in autoimmune liver diseases. Med Adv. 2023;1(2):97\u2013114.","journal-title":"Med Adv"},{"issue":"8","key":"1396_CR46","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1039\/C5FO00214A","volume":"6","author":"S Peng","year":"2015","unstructured":"Peng S, Yao J, Liu Y, Duan D, Zhang X, Fang J. Activation of Nrf2 target enzymes conferring protection against oxidative stress in PC12 cells by ginger principal constituent 6-shogaol. Food Funct. 2015;6(8):2813\u201323.","journal-title":"Food Funct"},{"issue":"9","key":"1396_CR47","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/aps.2013.57","volume":"34","author":"G Park","year":"2013","unstructured":"Park G, Kim HG, Ju MS, Ha SK, Park Y, Kim SY, et al. 6-Shogaol, an active compound of ginger, protects dopaminergic neurons in Parkinson\u2019s disease models via anti-neuroinflammation. Acta Pharmacol Sin. 2013;34(9):1131\u20139.","journal-title":"Acta Pharmacol Sin"},{"key":"1396_CR48","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.biopha.2017.06.038","volume":"93","author":"TY Li","year":"2017","unstructured":"Li TY, Chiang BH. 6-Shogaol induces autophagic cell death then triggered apoptosis in colorectal adenocarcinoma HT-29 cells. Biomed Pharmacother. 2017;93:208\u201317.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"1396_CR49","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi Y, Massagu\u00e9 J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113(6):685\u2013700.","journal-title":"Cell"},{"issue":"5","key":"1396_CR50","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1053\/jhep.2001.28457","volume":"34","author":"DM Bissell","year":"2001","unstructured":"Bissell DM, Roulot D, George J. Transforming growth factor beta and the liver. Hepatology (Baltimore, MD). 2001;34(5):859\u201367.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"1","key":"1396_CR51","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s42255-018-0013-8","volume":"1","author":"JD Rabinowitz","year":"2019","unstructured":"Rabinowitz JD, Mutlu GM. A metabolic strategy to reverse fibrosis? Nat Metab. 2019;1(1):12\u20133.","journal-title":"Nat Metab"},{"issue":"1","key":"1396_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01097-6","volume":"7","author":"H Zeng","year":"2022","unstructured":"Zeng H, Pan T, Zhan M, Hailiwu R, Liu B, Yang H, et al. Suppression of PFKFB3-driven glycolysis restrains endothelial-to-mesenchymal transition and fibrotic response. Signal Transduct Target Ther. 2022;7(1):303.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"1396_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05305-7","volume":"13","author":"S Xu","year":"2022","unstructured":"Xu S, Cheuk YC, Jia Y, Chen T, Chen J, Luo Y, et al. Bone marrow mesenchymal stem cell-derived exosomal miR-21a-5p alleviates renal fibrosis by attenuating glycolysis by targeting PFKM. Cell Death Dis. 2022;13(10):876.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1396_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-019-0324-8","volume":"17","author":"F Wang","year":"2019","unstructured":"Wang F, Jia Y, Li M, Wang L, Shao J, Guo Q, et al. Blockade of glycolysis-dependent contraction by Oroxylin A via inhibition of lactate dehydrogenase-a in hepatic stellate cells. Cell Commun Signal. 2019;17(1):11.","journal-title":"Cell Commun Signal"},{"issue":"2","key":"1396_CR55","doi-asserted-by":"publisher","DOI":"10.21037\/atm-21-4222","volume":"10","author":"Q Chu","year":"2022","unstructured":"Chu Q, Gu X, Zheng Q, Zhu H. Regulatory mechanism of HIF-1alpha and its role in liver diseases: a narrative review. Ann Transl Med. 2022;10(2):109.","journal-title":"Ann Transl Med"},{"issue":"2","key":"1396_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s10522-025-10208-z","volume":"26","author":"R Thapa","year":"2025","unstructured":"Thapa R, Marianesan AB, Rekha A, Ganesan S, Kumari M, Bhat AA, et al. Hypoxia-inducible factor and cellular senescence in pulmonary aging and disease. Biogerontology. 2025;26(2):64.","journal-title":"Biogerontology"},{"issue":"9","key":"1396_CR57","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1016\/j.sjbs.2021.07.038","volume":"28","author":"S Jia","year":"2021","unstructured":"Jia S, Zhang H, Li L, Wang F, Zhang B. Shogaol potentiates sevoflurane mediated neuroprotection against ischemia\/reperfusion-induced brain injury via regulating apoptotic proteins and PI3K\/Akt\/mTOR\/s6K signalling and HIF-1alpha\/HO-1 expression. Saudi J Biol Sci. 2021;28(9):5002\u201310.","journal-title":"Saudi J Biol Sci"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01396-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01396-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01396-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T08:02:20Z","timestamp":1779868940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01396-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1396"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01396-y","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments involving animals were in accordance with institutional animal welfare guidelines and approved by the Institutional Animal Care and Use Committee of Anhui Medical University (No.\u00a0LLSC20251114).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}